Patients with homozygous or compound heterozygous FHBL present symptoms that are identical to those of abetalipoproteinemia caused by mutations in the microsomal triglyceride transfer protein (MTP) gene [4,11]. The gene discussed is MTTP; the disease is abetalipoproteinemia.